The treatment of leprosy.
D000328:Adult; D000818:Animals; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004893:Erythema Nodosum / Q000188:drug therapy; D005000:Ethionamide / Q000627:therapeutic use; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D009166:Mycobacterium leprae / Q000187:drug effects; D010349:Patient Compliance; D011515:Prothionamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D011515:Prothionamide; D003622:Dapsone; D002991:Clofazimine; D005000:Ethionamide; D012293:Rifampin